Could Kyowa Kirin be eyeing ophthalmology use for cancer dru...

Kyowa Kirin has bought back rights outside of cancer to tivozanib, amending an agreement dating back to 2006 with AVEO, and opening up the possibility of research in ophthalmology.

Alzheimer's blood test could boost research after successive...

A blood test could be used to diagnose Alzheimer’s before symptoms arise, providing an alternative to expensive brain scans and speeding up recruitment to badly-needed clinical trials.

Novo extends R&D alliance with AI specialist e-Therapeutics

FDA fast-tracks NeuroVive's traumatic brain injury drug

The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma NeuroVive, hastening its development and review.

Vertex’ chief Leiden to step down, with CMO named successor

Symonds confirmed as new GSK chairman amid CEO's business re...

GlaxoSmithKline has confirmed that it has hired Jonathan Symonds as chairman, confirming press speculation that the former Novartis and AstraZeneca finance chief was in the frame to replace